This activity is supported by an educational grant from Merck Sharp & Dohme, and Amgen.
Adoption of Biosimilars: Prescribers, Pharmacy and Payer Perspectives
Steven D. Lucio, PharmD, BCPS
Clinical Solutions and Pharmacy Program Development
Debra Gordon, MS
Highland Park, Illinois
At completion of this activity, the participant will be able to:
Pharmacists and managed care professionals.
Type of activity:
April 12, 2016
April 12, 2017
Estimated time to complete activity:
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEUs) under the ACPE universal activity number 0290-0000-16-048-H01-P. The activity is available for CE credit through April 12, 2017.
Instructions for Completing the Activity and Receiving CPE Credit
Participants must read the article in its entirety, complete the online pre-test, post-test and activity evaluation to receive credit. A passing score of 70% is required on the post-test. Participants receiving a failing grade on the post-test will be permitted to retake it at no cost. After successful completion of the online post-test and activity evaluation, your credit will be uploaded to CPE Monitor
. You may view your credit within 48 hours at
Your CE credit will be automatically uploaded to CPE Monitor
. Please ensure that your Pharmacy Times account is updated with your NABP e-profile ID number and your date of birth. Participation data will not be uploaded into CPE Monitor
if you do not have your NABP e-profile ID number and date of birth entered into your profile on
, has the following relevant financial relationships with commercial interests to disclose.
Steven Lucio, PharmD, BCPS
The following contributors have no relevant financial relationships with commercial interests to disclose
Debra Gordon, MS
Pharmacy Times Continuing Education
—David Heckard; Maryjo Dixon, RPh; Donna Fausak; Nathalie Harden; and Tara DeLorenzo
The American Journal of Pharmacy Benefits
— Nicole Beagin
An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
For Pharmacists Credit (CPE) only: Start Activity